<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Pain Med</journal-id><journal-id journal-id-type="iso-abbrev">Pain Med</journal-id><journal-id journal-id-type="pmc-domain-id">2894</journal-id><journal-id journal-id-type="pmc-domain">painmed</journal-id><journal-id journal-id-type="publisher-id">painmedicine</journal-id><journal-title-group><journal-title>Pain Medicine: The Official Journal of the American Academy of Pain Medicine</journal-title></journal-title-group><issn pub-type="ppub">1526-2375</issn><issn pub-type="epub">1526-4637</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10690857</article-id><article-id pub-id-type="pmcid-ver">PMC10690857.1</article-id><article-id pub-id-type="pmcaid">10690857</article-id><article-id pub-id-type="pmcaiid">10690857</article-id><article-id pub-id-type="pmid">37551941</article-id><article-id pub-id-type="doi">10.1093/pm/pnad103</article-id><article-id pub-id-type="publisher-id">pnad103</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Co-Morbid Pain &amp; Substance Use Disorders Section</subject><subj-group subj-group-type="category-toc-heading"><subject>Original Research Article</subject></subj-group></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00010</subject></subj-group></article-categories><title-group><article-title>Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6307-6369</contrib-id><name name-style="western"><surname>Andraka-Christou</surname><given-names initials="B">Barbara</given-names></name><degrees>JD, PhD</degrees><aff>
<institution>School of Global Health Management &amp; Informatics, University of Central Florida</institution>, Orlando, FL 32801, <country country="US">United States</country></aff><aff>
<institution>Department of Internal Medicine (Secondary Joint Appointment), University of Central Florida</institution>, Orlando, FL 32827, <country country="US">United States</country></aff><xref rid="pnad103-cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>McAvoy</surname><given-names initials="E">Elizabeth</given-names></name><degrees>BSPA, BA</degrees><aff>
<institution>O'Neill School of Public and Environmental Affairs, Indiana University</institution>, Bloomington, IN 47405, <country country="US">United States</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gordon</surname><given-names initials="AJ">Adam J</given-names></name><degrees>MD, MPH</degrees><aff>
<institution>Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center, VA Salt Lake City Health Care System</institution>, Salt Lake City, UT 84108, <country country="US">United States</country></aff><aff>
<institution>Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine</institution>, Salt Lake City, UT 84108, <country country="US">United States</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ohama</surname><given-names initials="M">Maggie</given-names></name><degrees>BS</degrees><aff>
<institution>The Cardiac and Vascular Institute</institution>, Gainesville, FL 32605, <country country="US">United States</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brach</surname><given-names initials="M">Marilyn</given-names></name><aff>
<institution>Trinity College</institution>, Hartford, CT 06106, <country country="US">United States</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Taylor</surname><given-names initials="EA">Erin A</given-names></name><degrees>PhD, MSPH</degrees><aff>
<institution>RAND Corporation</institution>, Santa Monica, CA 90401, <country country="US">United States</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vaiana</surname><given-names initials="M">Mary</given-names></name><degrees>PhD</degrees><aff>
<institution>RAND Corporation</institution>, Santa Monica, CA 90401, <country country="US">United States</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Saloner</surname><given-names initials="B">Brendan</given-names></name><degrees>PhD</degrees><aff>
<institution>Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University</institution>, Baltimore, MD 21205, <country country="US">United States</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stein</surname><given-names initials="BD">Bradley D</given-names></name><degrees>MD, PhD</degrees><aff>
<institution>RAND Corporation</institution>, Pittsburgh, PA 15238, <country country="US">United States</country></aff></contrib></contrib-group><author-notes><corresp id="pnad103-cor1"><italic toggle="yes">Corresponding author</italic>:&#160;School of Global Health Management &amp; Informatics, University of Central Florida, 525 W Livingston Street, Suite 401, Orlando, FL 32801,&#160;United States. Email:&#160; <email>barbara.andraka@ucf.edu</email>&#160;</corresp></author-notes><pub-date pub-type="collection"><month>12</month><year>2023</year></pub-date><pub-date pub-type="epub" iso-8601-date="2023-08-08"><day>08</day><month>8</month><year>2023</year></pub-date><volume>24</volume><issue>12</issue><issue-id pub-id-type="pmc-issue-id">450137</issue-id><fpage>1306</fpage><lpage>1317</lpage><history><date date-type="received"><day>16</day><month>5</month><year>2023</year></date><date date-type="rev-recd"><day>07</day><month>7</month><year>2023</year></date><date date-type="accepted"><day>28</day><month>7</month><year>2023</year></date><date date-type="corrected-typeset"><day>25</day><month>8</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>08</day><month>08</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>08</day><month>08</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-08-08 00:25:17.200"><day>08</day><month>08</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref>https://academic.oup.com/pages/standard-publication-reuse-rights</ali:license_ref><license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://academic.oup.com/pages/standard-publication-reuse-rights">https://academic.oup.com/pages/standard-publication-reuse-rights</ext-link>)</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="pnad103.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pnad103.pdf"/><abstract><title>Abstract</title><sec id="s1"><title>Background</title><p>In response to the opioid crisis, U.S. states have passed laws requiring urine drug testing (UDT) when opioid analgesics are prescribed for chronic pain. We sought to identify state law UDT requirements.</p></sec><sec id="s2"><title>Methods</title><p>We searched NexisUni legal database using terms related to UDT, chronic pain, and opioids. We included laws effective during spring 2022 that required UDT when opioids were prescribed for chronic pain. We performed deductive content analysis, coding laws for mandated UDT frequency, type of clinician and type of payer to whom the law applied, and circumstances under which UDT was mandated.</p></sec><sec id="s3"><title>Results</title><p>We found 32 laws across 13 states that met our inclusion criteria. UDT requirements varied substantially by state, including with regard to the type of clinician to whom the law applied, the mandated frequency of UDT (eg, at initiation/assessment, at least annually, more than once per year), and the circumstances in which UDT was mandated (eg, patient had substance use disorder; dosage/day threshold).</p></sec><sec id="s4"><title>Discussion</title><p>Relatively few states have UDT mandates associated with prescribing opioids as chronic pain treatment. When developing policy indicators for empirical studies, researchers evaluating how UDT policy affects health outcomes must consider the complexity and lack of uniformity of UDT requirements. In addition, even if states mandate UDT, it is unclear whether clinicians understand the best way to use the test results.</p></sec></abstract><kwd-group><kwd>opioids</kwd><kwd>analgesics</kwd><kwd>laws</kwd><kwd>policies</kwd><kwd>urine drug screening</kwd><kwd>urine drug testing</kwd><kwd>chronic pain</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source><institution-wrap><institution>NIH</institution><institution-id institution-id-type="DOI">10.13039/100000002</institution-id></institution-wrap></funding-source></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>National Institute on Drug Abuse</institution><institution-id institution-id-type="DOI">10.13039/100000026</institution-id></institution-wrap></funding-source><award-id># 5R01DA045055-02</award-id></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>RAND Corporation</institution><institution-id institution-id-type="DOI">10.13039/100004459</institution-id></institution-wrap></funding-source></award-group></funding-group><counts><page-count count="12"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>